An Overview on Biomarkers of Inflammation and Disease Severity in Children with Congenital Cardiac Shunts
Keywords:
Congenital heart disease; Left-to-right cardiac shunt; Interleukin-1β; Interleukin-10; Intestinal inflammation; Gut-heart axis; Pediatric heart failure; Cytokines.Abstract
Background: Congenital heart disease (CHD) comprises a heterogeneous group of structural and functional abnormalities of the heart and great vessels that arise from abnormal cardiac development during fetal life. Among these lesions, left-to-right cardiac shunts may produce pulmonary overcirculation, systemic venous congestion, and reduced effective systemic cardiac output, particularly when the shunt is hemodynamically significant. These hemodynamic disturbances may impair splanchnic perfusion and contribute to intestinal congestion, increased intestinal permeability, and disruption of the gut barrier, thereby promoting bacterial translocation and systemic inflammatory activation. Inflammatory cytokines appear to have an important role in this process. Interleukin-1β (IL-1β) is a major pro-inflammatory cytokine involved in innate immune activation, myocardial inflammation, and inflammatory signaling, whereas interleukin-10 (IL-10) acts as an anti-inflammatory cytokine that limits excessive immune responses and promotes restoration of immune homeostasis. In decompensated pediatric patients with left-to-right cardiac shunts, an imbalance between pro-inflammatory IL-1β activity and the counter-regulatory effects of IL-10 may reflect the severity of intestinal and systemic inflammation. Assessment of these cytokines, individually or as part of a pro-/anti-inflammatory profile, may therefore provide additional insight into the inflammatory burden associated with heart failure and gut-barrier dysfunction and may have potential diagnostic and prognostic value in affected children.